A Study Based on Metabolomics, Network Pharmacology, and Experimental Verification to Explore the Mechanism of Qinbaiqingfei Concentrated Pills in the treatment of Mycoplasma Pneumonia

Abstract

Qinbaiqingfei concentrated pills (QB) are a commonly used medicine for the treatment of mycoplasma pneumonia in China, and the mechanism of action of QB needs to be studied further. Therefore, we use a combination of metabolomics and network pharmacology to clarify the mechanism of QB. Nontarget metabolomics studies were performed on rat serum, urine, and lung tissues, and 56 therapeutic biomarkers were found. Subsequently, the components of QB absorbed into the blood and lung tissues were clarified, and based on this finding, the core target of network pharmacology was predicted. The enrichment analysis of biomarkers–genes finally confirmed their close relationship with the NF-κB signaling pathway. By western blotting expression of the proteins in the lung tissue–related signaling pathways, it is finally confirmed that QB inhibits the NF-κB signaling pathway through SIRT1, IL-10 and MMP9, CTNNB1, EGFR, and other targets. It plays a role in regulating immunity, regulating metabolism, and treating diseases.

RIPK1 and RIPK3 inhibitors: potential weapons against inflammation to treat diabetic complications

“…These proteins function as transcription factors that form dimers and regulate the expression of genes encoding acute phase response proteins, cytokines, immunomodulatory molecules, and cell adhesion molecules, among others (58)(59)(60). NF-kB is involved in various biological processes, including immune and inflammatory responses, as well as tumorigenesis, through the regulation of gene expression (61,62). Numerous extracellular stimulatory signals, such as proinflammatory cytokines, physicochemical stimuli, LPS, and others, can activate the NF-kB signaling pathway (63, 64).…”

Mechanisms of Zhixiao Tang on Anti-Inflammatory Multiple Targets and Multiple Components: Metabonomics Combined with Database Mining Technology

“… 3 , 4 The application of metabolomics in the treatment of pneumonia with Chinese medicine has been reported, mainly in animal and human samples. 5 Animal models can partially simulate the pathological changes of pneumonia, but their species differences with humans pose many hidden dangers for clinical translation. Cellular metabolomics, however, utilizes human cell models to effectively detect endogenous cellular metabolites, thereby accurately reflecting the biomarker information pertaining to cellular life activities.…”

Therapeutic Effects of Retinoic Acid in Lipopolysaccharide-Induced Cardiac Dysfunction: Network Pharmacology and Experimental Validation

“…Currently, the network pharmacological approach can be employed to forecast the correlation between targets and diseases. 19 , 20 The network pharmacological approach was deemed as a new method of medicine design. 21 , 22 Network pharmacology methods are developing rapidly and have been leveraged to find new treatment methods, ameliorating the approved drugs and expanding the application scenarios of clinical medicines.…”